Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-05

FDA Approved: MILRINONE LACTATE — Supplemental Application (Shandong New Time Pharmaceutical Co., Ltd.)

View source ↗

Summary

FDA approved a supplemental ANDA for milrinone lactate from Shandong New Time Pharmaceutical Co., Ltd., authorizing the generic product for distribution. The ap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Milrinone lactate (milrinone lactate)

Snippet

SUPPL AP for MILRINONE LACTATE (MILRINONE LACTATE)